Question Title

Moderator: Dr Andrew Gennery
Newcastle University and Great North Children’s Hospital, Newcastle upon Tyne, UK

Dr Claire Booth

UCL Great Ormond Street Institute of Child Health, London, UK

Dr Maria Pia Cicalese

San Raffaele Scientific Institute, Milan, Italy

Question Title

* 1. How well did the webcast fulfil the following learning objectives?

  Strongly Agree Agree Neutral Disagree Strongly Disagree
Explain the underlying biology as well as the screening and detection methods for ADA-SCID
Describe and debate the current treatment algorithm for ADA deficiency
Summarise the latest advances in gene therapy for ADA-SCID, notably gammaretroviral and lentiviral vector gene therapies, and how these novel treatments can be applied to every day clinical practice 

Question Title

* 2. How would you rate the overall quality of the webinar?
10=Excellent, 1=Poor

Question Title